Search research articles
Contact Us
Filters
Showing results (251-260 of 282) with videos related to
Page
of 29
Sort By:
Genes & Diseases
|
August 17, 2023
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
Kevin Qin, Michael Yu, Jiaming Fan, et al.
BMC Cancer
|
May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
Matthew N Mills, Afrin Naz, Chetna Thawani, et al.
Neuro-Oncology
|
November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Journal of Neuro-Oncology
|
August 27, 2024
Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study
Stylianos Pikis, Georgios Mantziaris, Maria Protopapa, et al.
Acta Cardiologica Sinica
|
June 8, 2022
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
Tzung-Dau Wang, Chern-En Chiang, Ting-Hsing Chao, et al.
Elife
|
August 13, 2025
PRMT1-mediated metabolic reprogramming promotes leukemogenesis
Hairui Su, Yong Sun, Han Guo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
Ammoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Breast Cancer Research and Treatment
|
October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
Matthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Neuro-Oncology Advances
|
March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
Solmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
Journal of Neuro-Oncology
|
September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report
Vaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 282) with videos related to
Sort By:
Page
of 29
Genes & Diseases
|
August 17, 2023
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
Kevin Qin, Michael Yu, Jiaming Fan, et al.
BMC Cancer
|
May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
Matthew N Mills, Afrin Naz, Chetna Thawani, et al.
Neuro-Oncology
|
November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Journal of Neuro-Oncology
|
August 27, 2024
Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study
Stylianos Pikis, Georgios Mantziaris, Maria Protopapa, et al.
Acta Cardiologica Sinica
|
June 8, 2022
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
Tzung-Dau Wang, Chern-En Chiang, Ting-Hsing Chao, et al.
Elife
|
August 13, 2025
PRMT1-mediated metabolic reprogramming promotes leukemogenesis
Hairui Su, Yong Sun, Han Guo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
Ammoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Breast Cancer Research and Treatment
|
October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
Matthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Neuro-Oncology Advances
|
March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
Solmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
Journal of Neuro-Oncology
|
September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report
Vaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.
Page
of 29